EDAP TMS SA (EDAP) - Total Liabilities

Latest as of March 2026: $61.96 Million USD

Based on the latest financial reports, EDAP TMS SA (EDAP) has total liabilities worth $61.96 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check EDAP asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

EDAP TMS SA - Total Liabilities Trend (1997–2025)

This chart illustrates how EDAP TMS SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of EDAP TMS SA.

EDAP TMS SA Competitors by Total Liabilities

The table below lists competitors of EDAP TMS SA ranked by their total liabilities.

Company Country Total Liabilities
Pyrum Innovations AG
OL:PYRUM
Norway Nkr42.95 Million
Arrowmark Financial Corp
NASDAQ:BANX
USA $32.21 Million
Auna S.A.
NYSE:AUNA
USA $5.53 Billion
Fasadgruppen Group AB
ST:FG
Sweden Skr4.36 Billion
Digital Currency X Technology Inc.
NASDAQ:DCX
USA $709.20 Million
Sea Sonic Electronics Co Ltd
TWO:6203
Taiwan NT$921.40 Million
Bulten AB
ST:BULTEN
Sweden Skr2.68 Billion
Trivago NV
NASDAQ:TRVG
USA $145.15 Million

Liability Composition Analysis (1997–2025)

This chart breaks down EDAP TMS SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EDAP equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.34 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 6.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.86 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EDAP TMS SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EDAP TMS SA (1997–2025)

The table below shows the annual total liabilities of EDAP TMS SA from 1997 to 2025.

Year Total Liabilities Change
2025-12-31 $59.58 Million +31.92%
2024-12-31 $45.17 Million +30.45%
2023-12-31 $34.62 Million +17.40%
2022-12-31 $29.49 Million +8.55%
2021-12-31 $27.17 Million -6.13%
2020-12-31 $28.95 Million +12.58%
2019-12-31 $25.71 Million +8.13%
2018-12-31 $23.78 Million +9.37%
2017-12-31 $21.74 Million -1.81%
2016-12-31 $22.14 Million -8.33%
2015-12-31 $24.15 Million +41.96%
2014-12-31 $17.01 Million -3.28%
2013-12-31 $17.59 Million -21.06%
2012-12-31 $22.28 Million -6.52%
2011-12-31 $23.84 Million -11.84%
2010-12-31 $27.04 Million -2.74%
2009-12-31 $27.80 Million +4.23%
2008-12-31 $26.67 Million -12.70%
2007-12-31 $30.55 Million +131.93%
2006-12-31 $13.17 Million +15.40%
2005-12-31 $11.42 Million +14.96%
2004-12-31 $9.93 Million -23.18%
2003-12-31 $12.93 Million +13.16%
2002-12-31 $11.42 Million -19.73%
2001-12-31 $14.23 Million -9.08%
2000-12-31 $15.65 Million -25.44%
1999-12-31 $20.99 Million +2.58%
1998-12-31 $20.46 Million +19.74%
1997-12-31 $17.09 Million --

About EDAP TMS SA

NASDAQ:EDAP USA Medical Distribution
Market Cap
$203.71 Million
Market Cap Rank
#17621 Global
#4162 in USA
Share Price
$5.44
Change (1 day)
-0.18%
52-Week Range
$1.81 - $5.45
All Time High
$12.49
About

EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more